ARCHIVES

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

This article is from The Cancer Letter archive.

Vol. 34 No. 28 | July 18, 2008

Download PDF Visit The Full Archive

Related Articles

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979